Arterial wave reflection is elevated in evening hemodialysis patients

Clinical and Experimental Hypertension

Volumn 30, Issue 3-4, 2008, Pages 173-181

  Takenaka, Tsuneo ^a   Mimura, Taku ^a   Kanno, Yoshihiko ^a   Ohno, Yoichi ^a   Suzuki, Hiromichi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Arterial stiffness; Cardiovascular diseases; Diabetes; Event; Hemodialysis

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATIN;

ADULT; AGE; ARTERIAL STIFFNESS; ARTERIAL WAVE REFLECTION; ARTICLE; BLOOD PRESSURE; CAUSE OF DEATH; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MALE; PROGNOSIS; PULSE RATE; PULSE WAVE;

AORTA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CIRCADIAN RHYTHM; ELASTICITY; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROGNOSIS; PULSATILE FLOW; RADIAL ARTERY; RENAL DIALYSIS;

EID: 42349103110     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960802064542     Document Type: Article

References (27)

1. Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin X, Maywood ES, Hastings MH, Reppert SM. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell. 1999 Jul 23;98(2):193-205.
2. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M, CAFE Investigators, Anglo-Scandinavian Cardiac Outcomes Trial Investigators, CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006 Mar 7;113(9):1213-1225.
3. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003 Mar 18;107(10):1401-1406.
4. Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O, Miyakawa M, Fukiyama K. Japanese Society of Hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res. 2003;26:771-782.
5. Patient Registration Committee, Japanese Society for Dialysis Therapy. An overview of regular dialysis treatment in Japan (as of 31 December 2002). Ther Apher Dial. 2004 Oct;8(5):358-382.
6. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001 Oct;38(4):932-937.
7. Takenaka T, Mimura T, Kanno Y, Suzuki H. Qualification of arterial stiffness as a risk factor to the progression of chronic kidney diseases. Am J Nephrol. 2005 Sep-Oct;25(5):417-424.
8. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J. 1993 Feb;14(2):160-167.
9. Takazawa K, Tanaka N, Takeda K, Kurosu F, Ibukiyama C. Underestimation of vasodilator effects of nitroglycerin by upper limb blood pressure. Hypertension. 1995 Sep;26(3):520-523.
10. Mahmud A, Feely J. Acute effect of caffeine on arterial stiffness and aortic pressure waveform. Hypertension. 2001 Aug;38(2):227-231.
11. Chirinos JA, Zambrano JP, Chakko S, Veerani A, Schob A, Willens HJ, Perez G, Mendez AJ. Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension. 2005;45:980-985.
12. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38: 434-438.
13. Covic A, Mardare N, Gusbeth-Tatomir P, Prisada O, Sascau R, Goldsmith DJ. Arterial wave reflections and mortality in haemodialysis patients - only relevant in elderly, cardiovascularly compromised? Nephrol Dial Transplant. 2006 Oct;21(10):2859-2866.
14. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW. Kidney disease as a risk factor for development of cardiovascular disease. Circulation. 2003 Oct 28;108(17):2154-2169.
15. Takenaka T, Suzuki H. New strategy to attenuate pulse wave velocity in haemodialysis patients. Nephrol Dial Transplant. 2005 Apr;20(4):811-816.
16. Ikeda N, Nishimura S, Kyo S, Komiyama N, Matsumoto K, Inoue T, Suzuki H. Valsartan cardio-renal protection in patients undergoing coronary angiography complicated with chronic renal insufficiency (VAL-CARP) trial: Rationale and design. Circ J. 2006 May;70(5):548-552.
17. Takenaka T, Kobayashi K, Suzuki H. Pulse wave velocity as an indicator of arteriosclerosis in hemodialysis patients. Atherosclerosis. 2004 Oct;176(2):405-409.
18. Suzuki H, Nakamoto H, Okada H, Sugahara S, Kanno Y. Self-measured systolic blood pressure in the morning is a strong indicator of decline of renal function in hypertensive patients with non-diabetic chronic renal insufficiency. Clin Exp Hypertens. 2002 May;24(4):249-260.
19. Carvalho MJ, van Den Meiracker AH, Boomsma F, Lima M, Freitas J, Veld AJ, Falcao De Freitas A. Diurnal blood pressure variation in progressive autonomic failure. Hypertension. 2000 Apr;35(4):892-897.
20. Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, Nishiyama A, Aihara A, Sekino M, Kikuya M, Ito S, Satoh H, Hisamichi S. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: A population-based observation in Ohasama, Japan. J Hypertens. 1998 Jul;16(7):971-975.
21. Nichols WW, Singh BM. Augmentation index as a measure of peripheral vascular disease state. Curr Opin Cardiol. 2002 Sep;17(5):543-551.
22. Ting CT, Chou CY, Chang MS, Wang SP, Chiang BN, Yin FC. Arterial hemodynamics in human hypertension. Effects of adrenergic blockade. Circulation. 1991 Sep;84(3):1049-1057.
23. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med. 1999 Apr 29;340(17):1321-1328.
24. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cateliotti A, Stancanelli B, Malatino LS. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation. 2002;105:1354-1359.
25. Robinson BM, Joffe MM, Berns JS, Pisoni RL, Port FK, Feldman HI. Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time. Kidney Int. 2005 Nov;68(5):2323-2330.
26. Hampl H, Hennig L, Rosenberger C, Gogoll L, Riedel E, Scherhag A. Proven strategies to reduce cardiovascular mortality in hemodialysis patients. Blood Purif. 2006;24(1):100-106.
27. Bodlaj G, Berg J, Biesenbach G. Diurnal variation of arterial stiffness and subendocardial perfusion noninvasively assessed using applanation tonometry in healthy young men. Wien Klin Wochenschr. 2005 May;117(9-10):348-352.